This pie chart shows STI vaccine and diagnostic R&D funding among US and international organizations.
Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.
This chart lists the top twenty organizations funding STI diagnostic and vaccine research.
Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.
This map shows the funding distribution of STI vaccine and diagnostic funding by country of institution.
Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.
This chart shows STI vaccine and diagnostic R&D funding by NIH institutes and centers and by topic.
Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.
This pie chart provides a breakdown research & development funding for STI vaccines and diagnostics by NIH institutes and centers.
Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.
This table shows STI vaccine and diagnostic research & development funding by pathogen.
Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.
This pie chart shows research & development funding for STI vaccines and diagnostics by topic.
Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.
This pie chart shows research & development funding for STI vaccines and diagnostics by sector — public and philanthropic.
Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.
The Coalition to Accelerate Access to Long-Acting PrEP brings together leading donors, agencies, and advocates aimed at a practical goal: jointly develop strategies and take coordinated action to identify and overcome access challenges to just-approved and future PrEP options. AVAC serves as the Secretariat.
This graphic presents key strategies for advocates to improve vaccine access, highlighting actions like influencing WHO guidelines, community education, addressing intellectual property barriers, and establishing voluntary access mechanisms.